Medtronic (NYSE:MDT) touted data for its In.Pact Admiral drug-coated balloon this week at the Vascular Interventional Advances (VIVA) 2017 conference. The company presented two-year, real-world data from the In.Pact Global study, as well as four-year results from the pivotal In.Pact SFA study. Data from the In.Pact Global study showed a 83.3% rate of freedom from clinically-driven target […]
Featured
Press release: Raumedic presents customized pharma solutions
(Press release) – For the first time after several years, Raumedic will be present at the pharma trade show CPhI Worldwide in Frankfurt, Germany. From October 24 to 26, the company will be showcasing a wide range of polymer products and components to professionals from the pharmaceutical industry, including drug delivery systems as well as […]
Fractyl Labs touts 1-year data for Revita DMR in T2D patients
Fractyl Laboratories touted data today showing sustained improvement in glycemic parameters after one year following a single treatment with its Revita duodenal mucosal resurfacing system in patients with Type II diabetes. “This is the first presentation of one-year data on the durability of the Revita DMR procedure in Type II diabetes. The Revita DMR procedure […]
US DHS warns of vulnerabilities in Smiths Medical Medfusion 4000 infusion pump
The US Dept. of Homeland Security’s Industrial Control Systems Cyber Emergency Response Team has released a warning over issues with Smiths Medical’s Medfusion 4000 wireless syringe infusion pump after discovering 8 cybersecurity vulnerabilities in the device. The notice is for versions 1.1, 1.5 and 1.6 Medfusion 4000 wireless syringe infusion pumps, according to the DHS […]
Novartis partners with nonprofit for novel malaria drug
David Hughes and his team at Novartis (NYSE:NVS) have screened nearly a million compounds to find a few to specifically target the drug-resistant plasmodium parasite that causes malaria. This technique – of throwing hundreds of thousands of drugs through a variety of high-throughput tests and hoping to find the ones that perform well – is common […]
Boehringer Ingelheim’s Jardiance cuts risk of cardiovascular death in T2D patients
Boehringer Ingelheim and Eli Lilly (NYSE:LLY) touted post-hoc analyses today showing that Jardiance reduced the risk of cardiovascular death in people with Type II diabetes and established cardiovascular disease, independent of blood sugar control at the start of the study. The companies also reported a reduced risk in cardiovascular death when Jardiance was added to first […]
Ascensia Diabetes Care partners for mobile insulin management app
Ascensia Diabetes Care and Quattro Folia said today that the companies are partnering to combine Ascensia’s Contour Next One blood glucose monitoring system and Quattro Folia’s Balansio mobile insulin management app. According to the deal, the Contour Next One meter will connect via Bluetooth to the Balansio mobile app and deliver blood glucose readings to […]
Study: Sanofi’s diabetes drug brings earlier blood sugar control than insulin glargine
A post-hoc analysis of two late-stage trials of Sanofi‘s (NYSE:SNY) Soliqua insulin glargine and lixisenatide injection showed that it provides blood sugar control earlier and in more adults than just insulin glargine, the company reported. The analysis was presented today at the European Association for the Study of Diabetes in Portugal. Researchers reviewed data from […]
Study: Children with asthma more likely to be prescribed unnecessary antibiotics
Kids with asthma are more likely to be prescribed antibiotics, despite the fact that they don’t need them more than kids without asthma, according to a study that is slated to be presented at the European Respiratory Society International Congress. Researchers from Erasmus University in the Netherlands pointed out that it’s possible that asthma symptoms […]
Report: Abbott still looking to pull Xience DES from Indian market
Abbott (NYSE:ABT) is still looking to pull its Xience Alpine drug-eluting stent from the Indian marketplace after the country’s regulatory body set significant price caps on stents earlier this year, according to an Indian Economic Times report. The company reportedly approached India’s National Pharmaceutical Pricing Authority looking to withdraw the Xience stent yet again due to caps, along […]